The Mycelium
Microdosing in the news and pop culture — the research that just dropped, the cultural moments worth paying attention to, and where we think the field is going.
commentary
2026: The Year the Field Stops Pretending It's One Thing
The psychedelic field in early 2026 is not having one conversation. It is having five or six at the same time, and they do not agree with each other. A map of where the work is, who is doing it, and where the quiet breaks are forming.
Read →commentary
Bryan Johnson, Psilocybin, and the Biohacker Crossover
The longevity-obsessed founder of Blueprint ran a 249-biomarker psilocybin experiment in November 2025, then livestreamed a six-hour macro dose to a million people. What his published data actually shows, and what it signals about where the biohacker community is going.
Read →commentary
The Imperial College Body of Work: What It Has Shown and What It Hasn't
For more than a decade, the Centre for Psychedelic Research at Imperial College London has produced some of the most-cited psilocybin studies in the modern literature. A careful look at what the research actually demonstrates, where the field has oversold it, and what questions the next decade needs to answer.
Read →
culture
The Mycelium Model: Why Community Changes Everything
How nature's underground network mirrors the way healing actually works. You were never meant to do this alone.
Read →
commentary
Why the 4th Awakening Period Changes Everything
The mainstream shift toward psychedelic wellness is accelerating. The science, the culture, and the desperation are all converging at the same moment.
Read →
